Commenting today on the Centers for Medicare & Medicaid Services’ proposed calendar year 2023 payment rule for hospital outpatients and ambulatory surgical centers, AHA said it supports the agency’s decision to end its unlawful cuts to 340B hospitals and urged the agency to promptly restore 340B hospital payments for CYs 2018-2022 without penalizing other hospitals. AHA also voiced support for the agency’s proposal to use Medicare claims data to calculate the monthly facility rate for Rural Emergency Hospitals, and urged the agency to detail the payment methodology and monitor its adequacy going forward. 
 
However, AHA strongly urged the agency to increase the rule’s proposed market basket update and reduce its productivity adjustment to reflect the unprecedented inflationary environment hospitals and health systems are experiencing. It also urged CMS not to add facet joint interventions to its prior authorization process, as other oversight mechanisms are available that do not delay appropriate care. 
 
Among other issues, AHA commented on CMS’s proposal to exempt rural Sole Community Hospitals from the site-neutral clinic visit payment cuts; organ acquisition payments; and a request for information regarding the use of CMS data to drive competition in health care marketplaces.

Related News Articles

Headline
The AHA July 26 submitted a letter expressing concerns in response to the recently introduced 340B Affording Care for Communities and Ensuring a Strong Safety-…
Headline
The AHA July 25 urged the Centers for Medicare & Medicaid Services to maintain the uninsured rate at 8.7% under the inpatient prospective payment system…
Headline
The AHA, 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers July 9 filed an amicus brief in a federal district…
Headline
The Centers for Medicare & Medicaid Services July 10 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…
Headline
A Mississippi judge July 1 denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of state law protecting 340B…